Expression of macrophage migration inhibitory factor in esophageal squamous cell carcinoma and effects of bile acids and NSAIDs

Carcinogenesis

Volumn 26, Issue 1, 2005, Pages 11-15

  Xia, Harry Hua Xiang ^a   Zhang, Shu Tian ^b   Lam, Shiu Kum ^a   Lin, Marie Chia Mi ^a   Kung, Hsiang Fu ^a   Wong, Benjamin Chun Yu ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BILE ACID; CHENODEOXYCHOLIC ACID; GLYCOCHENODEOXYCHOLIC ACID; MACROPHAGE MIGRATION INHIBITION FACTOR; MESSENGER RNA; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN E2;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESOPHAGUS CARCINOMA; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; BILE ACIDS AND SALTS; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 13444280556     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgh279     Document Type: Article

References (50)

1. Pisani,P., Parkin,D.M., Bray,F. and Ferlay,J. (1999) Estimates of the world-wide mortality from 25 cancers in 1990. Int. J. Cancer, 83, 18-29.
2. Souza,R.F. (2002) Molecular and biologic basis of upper gastrointestinal malignancy-esophageal carcinoma. Surg. Oncol. Clin. North. Am., 11, 257-272.
3. Stoner,G.D. and Gupta,A. (2001) Etiology and chemoprevention of esophageal squamous cell carcinoma. Carcinogenesis, 22, 1737-1746.
4. Calandra,T., Bernhagen,J., Mitchell,R.A. and Bucala,R. (1994) The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J. Exp. Med., 179, 1895-1902.
5. Lue,H., Kleemann,R., Calandra,T., Roger,T. and Bernhagen,J. (2002) Macrophage migration inhibitory factor (MIF): mechanisms of action and role in disease. Microb. Infect., 4, 449-460.
6. Huang,X.R., Hui,C.W.C., Chen,Y.X. et al. (2001) Macrophage migration inhibitory factor is an important mediator in the pathogenesis of gastric inflammation in rats. Gastroenterology, 121, 619-630.
7. Xia,H.H.X., Lam,S.K., Huang,X.R., Wong,W.M., Leung,S.Y., Yuen,S.T., Lan,H.Y. and Wong,B.C.Y. (2004) Helicobacter pylori infection is associated with increased expression of macrophage migration inhibitory factor by epithelial cells, T cells and macrophages in gastric mucosa. J. Infect. Dis., 190, 293-302.
8. Bucala,R. (2000) A most interesting factor. Nature, 408, 167-168.
9. Shimizu,T., Abe,R., Nakamura,H., Ohkawara,A., Suzuki,M. and Nishihira,J. (1999) High expression of macrophage migration inhibitory factor in human melanoma cells and its role in tumor cell growth and angiogenesis. Biochem. Biophys. Res. Commun., 264, 751-758.
10. Bin,Q., Johnson,B.D., Schauer,D.W., Casper,J.T. and Orentas,R.J. (2002) Production of macrophage migration inhibitory factor by human and murine neuroblastoma. Tumour Biol., 23, 123-129.
11. Meyer-Siegler,K. (2000) Increased stability of macrophage migration inhibitory factor (MIF) in DU-145 prostate cancer cells. J. Interferon Cytokine Res., 20, 769-778.
12. Bando,H., Matsumoto,G., Bando,M., Muta,M., Ogawa,T., Funata,N., Nishihira,J., Koike,M. and Toi,M. (2002) Expression of macrophage migration inhibitory factor in human breast cancer: association with nodal spread. Jpn. J. Cancer Res., 93, 389-396.
13. Takahashi,N., Nishihira,J., Sato,Y., Kondo,M., Ogawa,H., Ohshima,T., Une,Y. and Todo,S. (1998) Involvement of macrophage migration inhibitory factor (MIF) in the mechanism of tumor cell growth. Mol. Med., 4, 707-714.
14. Kamimura,A., Kamachi,M., Nishihira,J., Ogura,S., Isobe,H., Dosaka-Akita,H., Ogata,A., Shindoh,M., Ohbuchi,T. and Kawakami,Y. (2000) Intracellular distribution of macrophage migration inhibitory factor predicts die prognosis of patients with adenocarcinoma of the lung. Cancer, 89, 334-341.
15. Akbar,S.M., Abe,M., Murakami,H., Tanimoto,K., Kumagi,T., Yamashita,Y., Michitaka,K., Horiike,N. and Onji,M. (2001) Macrophage migration inhibitory factor in hepatocellular carcinoma and liver cirrhosis; relevance to pathogenesis. Cancer Lett., 171, 125-132.
16. He,X.X., Xia,H.H.X., Yang,Y. et al. (2003) Increased serum levels and epithelial expression of macrophage migration inhibitory factor in gastric cancer. Gastroenterology, 124, A556 (abstract).
17. Goldstein,S.R., Yang,G.Y., Curtis,S.K., Reuhl,K.R., Liu,B.C., Mirvish,S.S., Newmark,H.L. and Yang,C.S. (1997) Development of esophageal metaplasia and adenocarcinoma in a rat surgical model without the use of a carcinogen. Carcinogenesis, 18, 2265-2270.
18. Miwa,K., Sahara,H., Segawa,M., Kinami,S., Sato,T., Miyazaki,I. and Hattori,T. (1996) Reflux of duodenal or gastro-duodenal contents induces esophageal carcinoma in rats. Int. J. Cancer, 67, 269-274.
19. Pera,M., Brito,M.J., Poulsom,R., Riera,E., Grande,L., Hanby,A. and Wright,N.A. (2000) Duodenal-content reflux esophagitis induces the development of glandular metaplasia and adenosquamous carcinoma in rats. Carcinogenesis, 21, 1587-1591.
20. Zhang,F., Altorki,N.K., Wu,Y.C., Soslow,R.A., Subbaramaiah,K. and Dannenberg,A,J. (2001) Duodenal reflux induces cyclooxygenase-2 in the esophageal mucosa of rats: evidence for involvement of bile acids. Gastroenterology, 121, 1391-1399.
21. Corley,D.A., Kerlikowske,K., Verma,R. and Buffler,P. (2003) Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis. Gastroenterology, 124, 47-56.
22. Tang,H. and Yang,X.P. (2002) Effect of boanmycin on apoptosis and cell cycle of human esophageal cancer (Eca-109) cells. Aizheng, 21, 855-859 (Chinese).
23. Chesney,J., Metz,C., Bacher,M., Peng,T., Meinbardt,A. and Bucala,R. (1999) An essential role for macrophage migration inhibitory factor (MIF) in angiogenesis and the growth of a murine lymphoma. Mol. Med., 95, 181-191.
24. Yang,Y., Degranpre,P., Kharfi,A. and Akoum,A. (2000) Identification of macrophage migration inhibitory factor as a potent endothelial cell growth-promoting agent released by ectopic human endometrial cells. J. Clin. Endocrinol. Metab., 85, 4721-4727.
25. Ogawa,H., Nishihira,J., Sato,Y., Kondo,M., Takahashi,N., Oshima,T. and Todo,S. (2000) An antibody for macrophage migration inhibitory factor suppresses tumour growth and inhibits tumour-associated angiogenesis. Cytokine, 12, 309-314.
26. Craven,P.A., Pfanstiel,J. and DeRubertis,F.R. (1987) Role of activation of protein kinase C in the stimulation of colonic epithelial proliferation and reactive oxygen formation by bile acids. J. Clin. Invest., 79, 532-541.
27. Reddy,B.S., Watanabe,K., Weisburger,J.H. and Wynder,E.L. (1977) Promoting effect of bile acids in colon carcinogenesis in germ-free and conventional F344 rats. Cancer Res., 37, 3238-3242.
28. Shirvani,V.N., Ouatu-Lascar,R., Kaur,B.S., Omary,M.B. and Triadafilopoulos,G. (2000) Cyclooxygenase 2 expression in Barrett's esophagus and adenocarcinoma: ex vivo induction by bile salts and acid exposure. Gastroenterology, 118, 487-496.
29. Kaur,B.S. and Triadafilopoulos,G. (2002) Acid- and bile-induced PGE(2) release and hyperproliferation in Barrett's esophagus are COX-2 and PKC-epsilon dependent. Am. J. Physiol. Gastrointest. Liver Physiol., 283, G327-G334.
30. Zhang,F., Subbaramaiah,K., Altorki,N. and Dannenberg,A.J. (1998) Dihydroxy bile acids activate the transcription of cyclooxygenase-2. J. Biol. Chem., 273, 2424-2428.
31. Ratnasinghe,D., Tangrea,J., Roth,M.J., Dawsey,S., Hu,N., Anver,M., Wang,Q.H. and Taylor,P.R. (1999) Expression of cyclooxygenase-2 in human squamous cell carcinoma of the esophagus; an immunohistochemical survey. Anticancer Res., 19, 171-174.
32. Morris,C.D., Armstrong,G.R., Bigley,G., Green,H. and Attwood,S.E. (2001) Cyclooxygenase-2 expression in the Barrett's metaplasia-dysplasia-adenocarcinoma sequence. Am. J. Gastroenterol. 96, 990-996.
33. Fosslien,E. (2000) Molecular pathology of cyclooxygenase-2 in neoplasia. Ann. Clin. Lab. Sci., 30, 3-21.
34. Zhu,G.H., Wong,B.C., Eggo,M.C., Ching,C.K., Yuen,S.T., Chan,E.Y., Lai,K.C. and Lam,S.K. (1999) Non-steroidal anti-inflammatory drug-induced apoptosis in gastric cancer cells is blocked by protein kinase C activation through inhibition of c-myc. Br. J. Cancer, 79, 393-400.
35. Zhou,X.M., Wong,B.C., Fan,X.M., Zhang,H.B., Lin,M.C., Kung,H.F., Fan,D.M. and Lam,S.K. (2001) Non-steroidal anti-inflammatory drugs induce apoptosis in gastric cancer cells through up-regulation of bax and bak. Carcinogenesis, 22, 1393-1397.
36. Jiang,X.H., Lam,S.K., Lin,M.C., Jiang,S.H., Kung,H.F., Slosberg,E.D., Soh,J.W., Weinstein,I.B. and Wong,B.C. (2002) Novel target for induction of apoptosis by cyclo-oxygenase-2 inhibitor SC-236 through a protein kinase C-beta(1)-dependent pathway. Oncogene, 21, 6113-6122.
37. Li,M., Lotan,R., Levin,B., Tahara,E., Lippman,S.M. and Xu,X.C. (2000) Aspirin induction of apoptosis in esophageal cancer: a potential for chemoprevention. Cancer Epidemiol. Biomarkers Prev., 9, 545-549.
38. Souza,R.F., Shewmake,K., Beer,D.G., Cryer,B. and Spechler,S.J. (2000) Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells. Cancer Res., 60, 5767-5772.
39. Morgan,G.P. and Williams,J.G. (1994) Inflammatory mediators in the oesophagus. Gut, 35, 297-298.
40. Chang-Claude,J.C., Wahrendorf,J., Liang,Q.S., Rei,Y.G., Munoz,N., Crespi,M., Raedsch,R., Thurnham,D.I. and Correa,P. (1990) An epidemiological study of precursor lesions of esophageal cancer among young persons in a high-risk population in Huixian, China. Cancer Res. 50, 2268-2274.
41. Meyer-Siegler,K. (2001) COX-2 specific inhibitor, NS-398, increases macrophage migration inhibitory factor expression and induces neuroendocrine differentiation in C4-2b prostate cancer cells. Mol. Med., 7, 850-860.
42. Sampey,A.V., Hall,P.H., Mitchell,R.A., Metz,C.N. and Morand,E.F. (2001) Regulation of synoviocyte phospholipase A2 and cyclooxygenase 2 by macrophage migration inhibitory factor. Arth. Rheumat., 44, 1273-1280.
43. Hudson,J.D., Shoaibi,M.A., Maestro,R., Carnero,A., Hannon,G.J. and Beach,D.H. (1999) A proinflammatory cytokine inhibits p53 tumor suppressor activity. J. Exp. Med., 190, 1375-1382.
44. Mitchell,R.A., Liao,H., Chesney,J., Fingerle-Rowson,G., Baugh,J., David,J. and Bucala,R. (2002) Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response. Proc. Natl Acad. Sci. USA, 99, 345-350.
45. Fitzer,C.J., O'Brian,C.A., Guillem,J.G. and Weinstein,I.B. (1987) The regulation of protein kinase C by chenodeoxycholate, deoxycholate and several structurally related bile acids. Carcinogenesis, 8, 217-220.
46. Glinghammar,B., Inoue,H. and Rafter,J.J. (2002) Deoxycholic acid causes DNA damage in colonic cells with subsequent induction of caspases, COX-2 promoter activity and the transcription factors NF-kB and AP-1. Carcinogenesis, 23, 839-845.
47. Jenkins,G.J., Harries,K., Doak,S.H., Wilmes,A., Griffiths,A.P., Baxter,J.N. and Parry,J.M. (2004) The bile acid deoxycholic acid (DCA) at neutral pH activates NF-kappaB and induces IL-8 expression in oesophageal cells in vitro. Carcinogenesis, 25, 317-323.
48. Tselepis,C., Morris,C.D., Wakelin,D., Hardy,R., Perry,I., Luong,Q.T., Harper,E., Harrison,R., Attwood,S.E. and Jankowski,J.A. (2003) Upregulation of the oncogene c-myc in Barrett's adenocarcinoma: induction of c-myc by acidified bile acid in vitro. Gut, 52, 174-180.
49. Enzinger,P.C. and Mayer,R.J. (2003) Esophageal cancer. N. Engl. J. Med., 349, 2241-2252.
50. Mizobuchi,S., Furihata,M., Sonobe,H., Ohtsuki,Y., Ishikawa,T., Murakami,H., Kurabayashi,A., Ogoshi,S. and Sasaguri,S. (2000) Association between p53 immunostaining and cigarette smoking in squamous cell carcinoma of the esophagus. Jpn. J. Clin. Oncol., 30, 423-428.